Literature DB >> 10037654

Communicating risk reductions. Data were selectively used.

J McMurray.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10037654      PMCID: PMC1115043     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  16 in total

1.  The limits of lifestyle: re-assessing 'fatalism' in the popular culture of illness prevention.

Authors:  C Davison; S Frankel; G D Smith
Journal:  Soc Sci Med       Date:  1992-03       Impact factor: 4.634

2.  Communication about risk: the responses of primary care professionals to standardizing the 'language of risk' and communication tools.

Authors:  A Edwards; E Matthews; R Pill; M Bloor
Journal:  Fam Pract       Date:  1998-08       Impact factor: 2.267

3.  The underused miracle drugs: the statin drugs are to atherosclerosis what penicillin was to infectious disease.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1996-08-01       Impact factor: 2.778

4.  Sick individuals and sick populations.

Authors:  G Rose
Journal:  Int J Epidemiol       Date:  1985-03       Impact factor: 7.196

5.  The risk epidemic in medical journals.

Authors:  J A Skolbekken
Journal:  Soc Sci Med       Date:  1995-02       Impact factor: 4.634

6.  Ethical issues in risk factor intervention.

Authors:  A S Brett
Journal:  Am J Med       Date:  1984-04       Impact factor: 4.965

7.  Strategy of prevention: lessons from cardiovascular disease.

Authors:  G Rose
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-06

8.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

9.  Cholesterol-lowering therapy: what patients expect in return.

Authors:  W W Reed; J E Herbers; G L Noel
Journal:  J Gen Intern Med       Date:  1993-11       Impact factor: 5.128

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.